nirmatrelvir/ritonavirPaxlovidSARS-CoV-2COVID-19Clinical Trials OntarioUnity Health Toronto Research Ethics Board
…ent Therapeutics Committee. The first therapeutic arm evaluates nirmatrelvir/ritonavir (Paxlovid), administered two times per day for 5 days. The seco…